Indian pharma launches JEEV – a vaccine for Japanese Encephalitis
JEEV, a vaccine to tackle Japanese Encephalitis was launched by an Indian pharma, Biological E. Ltd. It is the country’s first indigenous vaccine to tackle JE. Priced at Rs 985, the vaccine will be...
View ArticleClik here to view.
Brand India hit: Ghanian firms marketing fake drugs from India?
At a time the Indian pharmaceutical industry is attempting to brand itself to counter allegations of exporting counterfeit drugs, Ghana’s Food and Drugs Authority (FDA) has accused three local...
View ArticleClik here to view.
Pharma giant Dr Reddy passes away
Kallam Anji Reddy, the founder chairman of Dr. Reddy’s Laboratories, passed away Friday at a hospital here following brief illness. He was 73. He is survived by wife Samrajyam, daughter Anuradha and...
View ArticleClik here to view.
Global Big Pharma targeting Indian pharmaceutical industry?
As Indian pharmaceutical companies face charges of selling counterfeit drugs in Africa, India has dubbed the allegations as ‘calculated attempts’ by Western cartels to destroy its march to provide...
View ArticleSami Labs eyes Indian market to boost sales
Leading pharma and nutraceutical export player Sami Labs on Monday unveiled a holistic strategy to increase its market share in India to 10 percent in the near future from two percent currently. ‘We...
View ArticleClik here to view.
Govt defends India’s pharma industry after Ranbaxy fiasco
Ranbaxy’s actions has put a dark shadow on India’s image of being the ‘Generic Capital of the World’ and has got the government defending its lucrative generic drug industry as ‘safe and tightly’...
View ArticleClik here to view.
Ranbaxy spurious drugs update: DCGI probe will take a month, Apollo suspends...
The DCGI will complete its preliminary examination into the charges that Ranbaxy pleaded guilty to in the US and whether those infringements have any ramifications in India, health secretary Keshav...
View ArticleRanbaxy gets assistance from the health ministry
New Delhi, June 7 (IANS): Backing pharma major Ranbaxy, who has been accused of marketing sub-standard medicines, the health ministry said there was nothing wrong with the quality of its drugs. ‘There...
View ArticleIs this the end of the Ranbaxy fairytale? Japanese owners thinking of...
Indian drug giants Ranbaxy Laboratories is facing an existential conundrum with Japanese owners Daiichi Sankyo, thinking of rechristening the company, perhaps in the hope that a name change will give...
View ArticleClik here to view.
Indian pharma to reach new heights but will it be able to maintain quality?
Pharmaceutical sales in India are expected to rise by 14.4 per cent to USD 27 billion in 2016 from last year, but the life sciences and health care industry is up against challenges such as quality...
View ArticleClik here to view.
India can become a global supplier of high quality medicines, says Cipla...
India can be a global leader in supplying affordable and high quality medicines to the world, and especially to the underdeveloped countries where such medicines do not reach the poor because of their...
View ArticleClik here to view.
Health in India — lack of generic drugs hurting national health policy
The Supreme Court decided to examine the issue that the national health policy of the country was hit due to non-availability of cheaper medicines and vaccines of same generic nature. A bench...
View Article
